Last reviewed · How we verify
Risk of seizure
Risk of seizure is a Small molecule drug developed by AstraZeneca. It is currently in Phase 2 development.
At a glance
| Generic name | Risk of seizure |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD) (NA)
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation (PHASE2)
- Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT (NA)
- Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders (NA)
- Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment
- Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation (NA)
- VCOM Pain Free Research Collaborative (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Risk of seizure CI brief — competitive landscape report
- Risk of seizure updates RSS · CI watch RSS
- AstraZeneca portfolio CI
Frequently asked questions about Risk of seizure
What is Risk of seizure?
Risk of seizure is a Small molecule drug developed by AstraZeneca.
Who makes Risk of seizure?
Risk of seizure is developed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).
What development phase is Risk of seizure in?
Risk of seizure is in Phase 2.
Related
- Manufacturer: AstraZeneca — full pipeline
- Compare: Risk of seizure vs similar drugs
- Pricing: Risk of seizure cost, discount & access